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The production of the pigment melanin in mammalian melanocytes requires the 
activity of at least three melanogenic enzymes, tyrosinase and tyrosinase-related 
proteins 1 and 2, which regulate the type and amount of melanin produced. 
However, the catalytic mechanism and specificity of the different tyrosinases are 
still under strong debate. Limited structural information has hampered the 
understanding of the molecular basis of the pathological mutations related to 
oculocutaneous albinism (OCA) and hyperpigmentation disorders. Here we 
present the first crystal structure of a mammalian tyrosinase family member. The 
intra-melanosomal domain of human tyrosinase-related protein 1 (TYRP1) 
reveals a typical tyrosinase fold and a Cys-rich subdomain that is unique to 
vertebrate melanogenic proteins. It contains two zinc ions as metal cofactors, as 
opposed to tyrosinase, which contains copper ions. In contrast to previous 
assumptions, human TYRP1 does not show hydroxylase nor oxidase activities, 
although a low level of these activities can be conferred to the enzyme by 
replacing zinc by redox-active copper ions. Indeed, the presence of zinc prevents 
oxidation of the substrate and suggests that TYRP1 might catalyze a 
protonation/deprotonation reaction, generating a phenolate intermediate that may 
be further oxidized by tyrosinase. Furthermore, crystal structures of TYRP1 with 
bound tyrosinase substrates and inhibitors show similar ligand binding modes 
that do not depend on the “substrate-guiding residues” at the active site entrance, 
as observed from mutated TYRP1 crystal structures mimicking the tyrosinase 
active site. Finally, the crystal structure of TYRP1 provides a structural 
rationalization of associated OCA3 related mutations, which can provide insights 
into the mechanisms of the disease and guide structure-based design of 
compounds for pigmentation disorder treatments. 
1.	Introduction	
Melanin is a natural pigment that is the primary determinant of the color of the 
skin, hair and iris of the eye (Rees, 2003; Slominski et al., 2005; Sturm and 
Larsson, 2009), and that protects the skin against DNA damage induced by UV 
radiation from the sun (Brenner and Hearing, 2008; Ortonne, 2002). It occurs 
mainly in two forms, eumelanin, a brown to black insoluble polymer and 
pheomelanin, a yellow to red sulfur-containing soluble polymer. Melanin 
biosynthesis involves three melanogenic enzymes, tyrosinase (TYR), tyrosinase-
related protein 1 (TYRP1), and tyrosinase-related protein 2 (TYRP2, also 
referred to as DCT) (García-Borrón and Solano, 2002; Yamaguchi and Hearing, 
2014) (Figure 1). TYR is the critical and rate-limiting enzyme. It catalyzes the 
hydroxylation of the amino acid L-tyrosine to L-3,4-dihydroxyphenylalanine (L-
DOPA) (monophenolase activity, EC 1.14.18.1) and the subsequent oxidation of 
L-DOPA to dopaquinone (diphenolase activity, EC 1.10.3.1). TYRP2 is a 
tautomerase responsible for the conversion of L-dopachrome, a spontaneous 
cyclization product of dopaquinone, into 5,6-dihydroxyindole-2-carboxylic acid 
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(DHICA) (Tsukamoto et al., 1992; Yokoyama et al., 1994).  TYRP1 has been 
reported to catalyze the oxidation of DHICA to indole-5,6-quinone-carboxylic 
acid (Jiménez-Cervantes et al., 1994; Kobayashi et al., 1994a, 1994b). The latter 
compound is one of the two building blocks of eumelanin (Figure 1).  
All three melanogenic enzymes are metal-containing glycoproteins with six to 
seven N-glycosylation sites and a single transmembrane α-helix. They share ~40% 
amino acid sequence identity and ~70% similarity, and have highly conserved 
active sites. They are exclusively expressed in melanocytes, and are localized in 
the melanosome organelles, where melanin synthesis takes place (Slominski et 
al., 2004). TYRP1 is the most abundantly expressed glycoprotein (Vijayasaradhi 
and Houchton, 1991). Full-length human TYRP1 contains 537 amino acid 
residues organized into four conserved regions, an N-terminal signal peptide 
(residues 1-24), an intra-melanosomal domain (25-477), a single-α-helix trans-
membrane domain (478-501), and a flexible C-terminal cytoplasmic domain 
(502-537) (Figure 2A and Figure 3). The intra-melanosomal domain contains a 
Cys-rich subdomain (residues 25-126) as well as a tyrosinase-like subdomain 
(residues 128-477) with two metal-ion-binding sites. The transmembrane 
domain anchors the protein to the melanosomal membrane, where it carries out 
its catalytic function. The cytoplasmic domain contains a di-leucine motif, which 
functions to divert the protein to the melanosomal membrane (Calvo et al., 1999; 
Setaluri, 2000). TYR and TYRP2 have a similar domain organization as TYRP1.  
Mutations in the TYR or TYRP1 genes result in oculocutaneous albinism (OCA) 
(Oetting, 2000; Sarangarajan and Boissy, 2001), a group of autosomal recessive 
disorders characterized by reduced production of melanin in skin, hair and eyes 
(Grønskov et al., 2007).  No pathological mutations have been reported so far for 
the TYRP2 gene. Mutations in the TYR gene cause OCA1 which can be 
subdivided into OCA1A and OCA1B depending on the severity of the disorder. 
Patients with OCA1A suffer from complete, lifelong absence of melanin, while 
OCA1B individuals retain the ability to tan (Oetting, 2000). The common 
features of OCA1 are white hair, pale skin, and light blue to pink iris (eye) with 
reduced visual acuity and intense photophobia (Grønskov et al., 2007). 
Mutations of the TYRP1 gene cause OCA3, a rufous or brown form of albinism 
(Boissy et al., 1996; Manga et al., 1997). Individuals suffering from OCA3 have 
a red-bronze skin color, ginger-red hair, and blue or brown irides (Boissy et al., 
1996; Ghanem and Fabrice, 2011; Kenny et al., 2012; Manga et al., 1997; 
Rooryck et al., 2006; Sarangarajan and Boissy, 2001; Yamada et al., 2011). In 
addition, TYR and TYRP1 variants are significantly associated with risk of 
melanoma (Duffy et al., 2010; Gerstenblith et al., 2010; Ghanem and Fabrice, 
2011; Gudbjartsson et al., 2008; Nan et al., 2009),  a malignant tumor of 
melanocytes that, because of its aggressive nature, causes the majority of deaths 
related to skin cancer (Siegel et al., 2016). 
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Although melanin exerts its photoprotective function in the skin, excess melanin 
production or abnormal distribution can cause unfavorable or irregular 
hyperpigmentation, such as over-tanning, age spots and melisma (Hsin-Su, 
1999). Therefore, skin-lightening compounds that directly inhibit melanogenic 
enzymes are of interest to the cosmetic and pharmaceutical industries for 
treatment of hyperpigmentation (Cruz-Vega et al., 2009; Park et al., 2010; Shin 
and Park, 2014). Furthermore, the inhibition of melanogenesis has been 
considered as a valid therapeutic target for the management of advanced 
melanotic melanomas (Slominski et al., 2009). This has generated a widespread 
interest in the development of compounds that inhibit melanogenic enzymes. 
Although 3D structures and the underlying catalytic mechanism of tyrosinases 
from different species have been extensively studied (Bijelic et al., 2015; Fujieda 
et al., 2013; Goldfeder et al., 2014; Ismaya et al., 2011; Kanteev et al., 2015; 
Matoba et al., 2006; Mauracher et al., 2014a; Sendovski et al., 2011), little is 
known about the structure and mechanism of mammalian tyrosinases and 
tyrosinase-related proteins, which in turn, hamper the understanding of the 
molecular basis of the pathological mutations related to OCA, and the design of 
specific mammalian tyrosinase inhibitors. In this study, we report the crystal 
structure of the intra-melanosomal domain of TYRP1 (without signal peptide, 
transmembrane domain and cytosolic tail), which provides a detailed structural 
basis for explaining OCA3-causing mutations. Furthermore, we show that 
human TYRP1 contains two zinc ions in the active site, making it unlikely to be 
a redox enzyme as had been assumed for the last three decades. In addition, we 
report structures of TYRP1 in complex with several tyrosinase substrates and 
inhibitors allowing us to identify the residues crucial for ligand binding. Such 





Figure 1: Melanin biosynthesis pathway (Aroca et al., 1993; Hearing and Tsukamoto, 
1991; Slominski et al., 2004). The eumelanin color ranges from black to brown, and that 
of pheomelanin from yellow to reddish, as indicated by the color filled spheres. 
2.	Results	
2.1	Overall	structure	of	TYRP1	
The 2.35 Å resolution crystal structure of the intra-melanosomal domain 
(residues 25-471) of human tyrosinase-related protein 1 (TYRP1) contains four 
molecules in the asymmetric unit (Table 1 and Figures 2-3). The four 
monomers are highly similar (RSMD of 0.3 Å) and most of the residues are well 
defined in the electron density maps, except the C-terminal residues from Ser470 
onwards and the C-terminal TEV cleavage site (ENLYFQ), which are disordered. 
The TYRP1 core structure shows a compact globular fold built up of two tightly-
interacting subdomains: the Cys-rich subdomain (residues 25-126) and the 



















subdomain has the typical tyrosinase fold, consisting of a four-helix bundle 
(α3, α4, α8 and α9; Figure 2B and Figure 3) connected by long loops. Its 
folding is most similar to that of Bacillus megaterium tyrosinase (BmTYR, PDB 
entry 3NM8) (Sendovski et al., 2011), with 32% sequence identity and an 
RMSD of 1.6 Å for 263 aligned amino acids (Figure 4). The most conspicuous 
differences are three insertions in TYRP1 comprising residues 156-183, 203-207, 
and 294-302, which form loop-like structures (Figure 4). These loops cluster 
together at one side of the tyrosinase-like subdomain, extending away from the 
entrance to the active site, and interacting with the Cys-rich subdomain (Figure 
4). Two disulfide bonds (Cys258-Cys261 and Cys290-Cys303) stabilize the 
tyrosinase subdomain (Figure 3, disulfide bonds 6 and 7, respectively). The 
Cys258-Cys261 disulfide bond conforms to the CXXC motif that was shown to 
be important for copper incorporation in Aspergillus oryzae tyrosinase 
(AoTYR)(Fujieda et al., 2013), although in TYRP1 it is ~15 Å away from the 
active site, without an obvious route to reach the active site (Figure 3). Thus, 
whether the Cys258 and Cys261 residues are involved in incorporation of a 
metal cofactor in the TYRP1 active site remains to be established. 
Figure 2. TYRP1 crystal structure. A. Domain organization of TYRP1. TYRP1 
comprises 537 amino acid residues organized into 4 conserved regions. Residues 1-24 
(yellow) constitute the signal peptide, residues 25-477 form the intra-melanosomal (or 
luminal) domain, which can be subdivided into the Cys-rich subdomain (residues 25-
126, green) and the tyrosinase-like subdomain (residues 127-477, blue), a 
transmembrane α-helix (residues 478-501, grey), and the cytoplasmic domain (residues 
502-537, orange). B. Overall structure of the intra-melanosomal domain, using the same 
colouring scheme as in A. The six Asn sites with N-linked sugars are shown as stick 
models and the disulfide bonds are shown in orange, as are the two metal ions (A and B). 
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The Cys-rich subdomain (residues 25-126, Figure 2B) is unique to vertebrate 
melanogenic proteins (Figure 3 and Figure 4). The core of the domain is formed 
by two pairs of short antiparallel β-strands (residues 62-66/98-102, and 116-
118/124-126; β1/β2 and β4/β5 in Figure 2B) from which long loops emerge. 
The loops have mostly a random coil conformation, but near the N-terminus a 
small α-helix is present (α1; residues 33-39; Figure 2B). The subdomain is 
stabilized by five disulfide bonds (Cys30 - Cys41, Cys42 - Cys65, Cys56 - 
Cys99, Cys101 - Cys110, and Cys113 - Cys122 (Figure 2B and Figure 3 - 
disulfide bonds 1, 2, 3, 4, and 5, respectively), which interconnect the loops to 
the core. As revealed by a structural alignment with PDBeFold (Krissinel and 
Henrick, 2004), the core has an EGF-like fold (SCOP family g.3.11.1). It is most 
similar to the structure of the human epidermal growth factor (PDB entry 1JL9) 
(Lu et al., 2001), but with an RMSD of 3.0 Å for the 39 aligned residues (Z-
score of 2.1, Figure 5). As hypothesized previously (Jackson et al., 1992), the 
disulfides in the TYRP1 Cys-rich core subdomain follow the [C1-C3, C2-C4, C5-
C6] signature pattern of EGF-like structures (corresponding to cysteines 42-65, 
56-99, 101-110, Figure 3) (Jackson et al., 1992).  
The Cys-rich subdomain interacts with the tyrosinase-like subdomain via its N-
terminus and the long loop (residues 67-97) emerging from its EGF-like core 
(Figure 2B). The domain is located far from the active site, at the opposite side 
of the molecule and, hence, it is unlikely that its presence will affect the activity 
of TYRP1 (Figure 2B). Nevertheless, it has been shown that its disulfide bonds 
are crucial for folding and maturation of melanogenic proteins (Negroiu et al., 
2000). Immature TYRP1 that cannot form the correct disulfide bonds is retained 
in the endoplasmic reticulum and targeted for degradation (Negroiu et al., 2000). 
Thus, although the precise function of the Cys-rich subdomain is still elusive and 
it does not seem to directly contribute to TYRP1 activity, correctly linked 
disulfide bonds are needed for maturation and functioning of TYRP1. 
Interestingly, it has been suggested that the Cys-rich subdomain of melanogenic 
proteins is involved in oligomerization (Jackson et al., 1992). However, we 
found that the intra-melanosomal domains of both TYRP1 and TYR elute as 
monomers based on size-exclusion chromatography (Figure 6A). Moreover, co-
elution of TYRP1 and TYR did neither produce a heterodimer (Figure 6B). 
Taken together, these observations suggest that the Cys-rich subdomain might 




Tyrosinase and tyrosinase-related proteins have been utilized as model substrates 
to study the maturation of glycoproteins in the mammalian secretory pathway 
due to the visual nature of their enzymatic activity (i.e. melanin production) 
(Branza-Nichita et al., 2000a; Wang and Hebert, 2006). The three human 
melanogenic enzymes TYR, TYRP1 and TYRP2 have six to seven N-
glycosylation motifs (Branza-Nichita et al., 2000a; Gupta et al., 2009), which 
constitute important signals to control and direct the correct folding of the 
corresponding polypeptides in the endoplasmic reticulum (Branza-Nichita et al., 
2000a; Helenius and Aebi, 2004; Svedine et al., 2004). Our TYRP1 structure 
shows that all six sites are glycosylated (Asn96, Asn104, Asn181, Asn304, 
Asn350 and Asn385) (Figure 2B and Figure 3). The number of carbohydrate 
residues that could be modeled varies, depending on the particular Asn residue 
and protein chain: one N-acetylglucosamine (NAG) moiety is present at Asn104, 
while two NAG moieties are recognizable at Asn304 and Asn385. Furthermore, 
α-(1,6)-fucose (FUC) moieties are seen linked to the NAG residues attached to 
Asn181 and Asn96. Interestingly, two NAG, one FUC and three mannose (MAN) 
residues are linked to Asn350 of chains B and D (Figure 2B), likely because the 
glycan is stabilized by interactions with neighboring molecules in the crystal 
(Figure 7). The mannose residues of the other glycan chains in TYRP1 are 
probably too flexible to be visible in the electron density maps. 
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Figure 3. TYRP1 secondary structure and sequence alignment of tyrosinases. 
Alignment of structurally characterized tyrosinase and tyrosinase-like proteins based on 
DALI (Holm and Rosenström, 2010) and ClustalW (Larkin et al., 2007).  Human 
TYRP1, TYRP2 and TYR; mushroom tyrosinases PPO3 (Z-score 21, 17% identity, 
PDB 2Y9W) (Ismaya et al., 2011) and PPO4 (Z-score 20, 20% identity, PDB 4OUA) 
(Mauracher et al., 2014a); the closest structural homolog Bacillus megaterium 
tyrosinase (BmTYR, Z-score 33, 33% identity, PDB 3NM8) (Sendovski et al., 2011); 
Aspergillus oryzae tyrosinase (AoTYR, Z-score 14, 18% identity, PDB 4J3Q) 
(Hakulinen et al., 2013); Streptomyces tyrosinase (StTYR, Z-score 29%, 30% identity, 
PDB 1WX4) (Matoba et al., 2006); walnut tyrosinase (JrTYR, Z-score 21, 19% identity, 
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PDB 5CE9) (Bijelic et al., 2015); and the oxygen transporter hemocyanin from Octopus 
dofleini (Hcy, Z-score 22, 20% identity, PDB 1JS8) (Cuff et al., 1998). Residues are 
numbered according to the TYRP1 amino acid sequence. The TYRP1 secondary 
structure elements are shown. Disulfide bonds and the involved cysteine residues are 
indicated in orange numbers. TYRP1 N-glycosylation sites are highlighted in light blue. 
Non-conserved residues in the active site are highlighted in green. Cys residues 
conforming to the EGF-like signature pattern [C1-C3, C2-C4, C5-C6] are indicated with 
an *. The CXXC motif potentially involved in copper incorporation is also indicated. 
 
Figure 4. Superposition of the crystal structures of TYRP1 and Bacillus 
megaterium TYR. BmTYR is represented as a grey cartoon and light grey surface 
(PDB 3NM8) (Sendovski et al., 2011). The tyrosinase-like subdomain of TYRP1 is 
shown in blue and the Cys-rich subdomain in light green. Loops with different lengths 
between the TYRP1 tyrosinase-like subdomain and BmTYR are indicated. Disulfide 
bonds stabilizing the TYRP1 tyrosinase-like subdomain are displayed in orange and the 
involved cysteine residues are indicated. The metal ions in the active site are shown in 
orange. A close-up of the active site structure is displayed in the inset. Metal-
coordinating histidine residues are shown as stick models. The A and B metal ions are 
displayed as pink spheres with the bridging water molecule in red. Hydrogen-bonding 





Figure 5. TYRP1 Cys-rich subdomain folds as an EGF-like domain. Structural 
alignment of the TYRP1 Cys-rich subdomain (residues 25-126, green) and the human 
Epidermal Growth Factor EGF-like domain (976-1017, grey, PDB 1JL9_A) based on 
DALI (Holm and Rosenström, 2010). Disulfide bonds are shown in yellow sticks and 
are numbered according to Figure 3. 
 
Figure 6. TYR and TYRP1 are monomeric in solution. (A) Analytical gel filtration 
profiles of TYR (19-456) and TYRP1 (25-471) overlapped from two individual runs on 
a Superdex 200 10/300 GL column. (B) Analytical gel filtration profile after incubation 
of a mixture of TYR (19-456) and TYRP1 (25-471) on a Superdex 200 10/300 GL 
column. Irrespective of being run separately or combined, the samples elute at 15 mL, 




Figure 7. N-linked glycans stabilize crystal contacts. The Asn181-linked N-glycan 
chain NAG2-FUC-MAN3 is involved in crystal contacts with neighboring molecules A, 
B, and D. Residues with hydrogen bonds to the glycan are displayed. A NAG2 moiety is 
attached to Asn350 of chains B and D and it has also interactions with neighboring 
molecules in the crystal. Molecule A is colored in orange, B in blue, C in pink, and D in 
green. 
2.2	The	TYRP1	active	site	contains	two	zinc	ions	
Despite the conservation of the metal-coordinating histidine residues, the three 
human melanogenic enzymes contain different metal ion cofactors, which 
presumably relates to their distinct catalytic functions in melanogenesis 
(Furumura et al., 1998). TYR has two copper ions in the active site (Solomon et 
al., 1996), TYRP2 uses zinc as cofactor (Solano et al., 1996), while the metal 
ions of TYRP1 are unclear (Furumura et al., 1998). The TYRP1 structure shows 
an active site region that resembles the classical binuclear copper site of type-3 
copper proteins (Bart et al., 1993; Cuff et al., 1998; Fujieda et al., 2013; Ismaya 
et al., 2011; Klabunde et al., 1998; Magnus et al., 1994b; Matoba et al., 2006; 
Mauracher et al., 2014a; Sendovski et al., 2011; Volbeda and Hol, 1989) (Figure 
4, right panel). However, X-ray fluorescence scans revealed the presence of zinc 
ions in the TYRP1 crystals (Figure 8A), while X-ray fluorescence scans of TYR 
crystals showed the presence of copper ions (Figure 8B). The presence of zinc 
in the TYRP1 active site was further confirmed by single-wavelength anomalous 
dispersion (SAD) at the zinc K absorption edge (9.67 keV), revealing that the 
TYRP1 active site contains two zinc ions located at the positions otherwise 
occupied by two copper ions in tyrosinases (Figure 9). Furthermore, an 
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additional Zn ion is located on a non-crystallographic dyad relating molecules A 
and B Figure 9, Zn ion number 9). This latter zinc ion is tetrahedrally 
coordinated by the side chains of residues His100 and Glu66 from both chains A 
and B. The observation of Zn2+ ions in TYRP1 but Cu2+ ions in TYR is very 
intriguing, since both TYRP1 and TYR were expressed and purified under 
similar conditions without the addition of any zinc or copper salts during cell 
growth and purification procedures (Figure 6). Which factors determine whether 
zinc or copper ions are incorporated in the human melanogenic enzymes remains 
unclear and requires further investigation.  
 
Figure 8. X-ray fluorescence spectrum of TYRP1 (A) and TYR (B) crystals. The 
black line indicates the raw counts (arbitrary scale) on the detector as a function of 
energy (keV). The red line indicates the fit based on the raw data. The two large peaks 
on the right of the spectrum are the Compton (inelastic) and the Rayleigh (elastic) 
scattering peaks of the incident beam. X-ray fluorescence emission energies (Kα and Kβ) 
for Zn and Cu are indicated.  
 81 
 
Figure 9. Zinc anomalous difference peaks in the TYRP1 crystal structure. 
Anomalous difference electron density map from TYRP1 X-ray diffraction data 
collected at the absorption K-edge of zinc (9.67 KeV) contoured at 3 σ. Nine anomalous 
difference peaks above 18 σ are present in the asymmetric unit, eight of them in the 
active sites and an additional one on a non-crystallographic dyad between molecules A 
and B. The peak heights at the zinc ion positions are indicated. The four molecules A, B, 
C, and D are displayed in different colors. 
2.3	 The	 binuclear	 zinc	 site	 resembles	 the	 type-3	 copper	 sites	 of	
tyrosinases	and	hemocyanins	
Like the binuclear copper site of tyrosinases, the binuclear zinc site of TYRP1 is 
located at the heart of two pairs of antiparallel α-helices (α3/α4 and α8/α9) 
(Figure 1B). These α-helices contribute five out of the six conserved histidine 
side chains that coordinate the two zinc ions (or copper ions in the case of 
tyrosinases) (Figure 3, right panel). Zn-A is coordinated by the Nε nitrogen 
atoms of His192 (α3), His215, and His224 (α4), and Zn-B binds to the Nε atoms 
of His377 (α8), His381 (α8), and His404 (α9; Figure 3). His215 is in the loop 
that connects α3 and α4. In some of the structurally characterized tyrosinases, 
this histidine is covalently bound via a thioether bond to a nearby cysteine 
(Bijelic et al., 2015; Fujieda et al., 2013; Ismaya et al., 2011; Mauracher et al., 
2014a). This is not the case in TYRP1, but nonetheless the His215 side chain 
conformation is well defined with a B-factor of 27.1 Å2, due to a hydrogen-
bonding interaction of its Nδ1 atom with the Asp212 carboxylate. Similarly, the 
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side chain conformations of the other zinc-ligating histidine side chains are also 
well defined. The His224, His377, and His381 side chains are stabilized by 
hydrogen bonds with nearby peptide carbonyl oxygen atoms, and those of 
His192 and His404 have water-mediated interactions. Both zinc-binding sites 
adopt a nearly planar trigonal geometry, with the zinc ions slightly out of the 
plane defined by the Nε2 atoms of their ligands. The distance between the Zn-A 
and Zn-B ions is 3.5 ± 0.1 Å. A bridging water molecule or hydroxyl group can 
be modeled with a distance of 2.3 ± 0.1 Å to the two zinc ions (Figure 4).  
2.4	In	vitro	activity	of	TYRP1	
The role of TYRP1 in melanogenesis has remained largely elusive. Various 
catalytic activities have been proposed, including catalase (Halaban and 
Moellmann, 1990), tyrosine hydroxylase (Zhao et al., 1994) and L-DOPA 
oxidase (Jimenez-Cervantes et al., 1993) activity, but generally it has been 
assumed that TYRP1 is a DHICA oxidase (Jiménez-Cervantes et al., 1994; 
Kobayashi et al., 1994a, 1994b). Comparing the activities of purified 
recombinant TYRP1 and TYR (intra-melanosomal domains; Figure 2A), it 
shows that TYRP1 is devoid of DHICA oxidase and tyrosinase activity while 
TYR has tyrosine hydroxylase, L-DOPA oxidase as well as DHICA oxidase 
activity (Figure 10). The absence of tyrosinase activity of TYRP1 is consistent 
with our finding that TYRP1 contains zinc in the active site. Zinc is not a redox-
active ion, and therefore TYRP1 does not show oxygen-activating or oxidase 
activity. 
To assess the importance of the metal ion cofactors, we have replaced the 
Zn2+/Cu2+ cofactors of TYRP1/TYR by Cu2+/Zn2+, respectively, after metal-free 
proteins had been obtained after incubation with potassium cyanide (Martinez-
Esparza et al., 1997). Cu-substituted TYRP1 (TYRP1-Cu) has clear DHICA 
oxidase activity comparable with that of native TYR (Figure 6C), but only low 
L-DOPA oxidase activity (Figure 6B). We did not detect tyrosine hydroxylase 
activity (Figure 6A), although this may be related to the lag phase problem 
commonly observed for the monophenolase activity of tyrosinases (Sánchez-
Ferrer et al., 1995; Solomon et al., 1996). Indeed, a prolonged on-plate 
hydroxylase activity assay with TYRP1-Cu (up to 160 min) shows that TYRP1-
Cu does have (low) hydroxylase activity (Figure 6D). In contrast, TYR-Zn has 
almost no activity, which is consistent with other studies in which zinc ions were 
shown to inhibit mushroom tyrosinase activity (Han et al., 2007). 
To investigate the effect of non-conserved residues on the catalytic properties of 
TYR and TYRP1, we replaced three residues in the active site of TYRP1 by the 
corresponding residues of TYR (TYRP1-3M; TYRP1Y362F-R374S-T391V) (Figure 3, 
residues highlighted in green), and also generated the copper variant TYRP1-
3M-Cu. The triple mutants have similar activity to that of native TYRP1 and 
TYRP1-Cu, respectively (Figure 6). Notably, the hydroxylase activity of 
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TYRP1-3M-Cu is significantly higher than that of TYRP1-Cu (Figure 6D), 
indicating that indeed TYRP1-3M-Cu mimics the active site of TYR.  
Overall, our results suggest that it is unlikely that TYRP1 is a redox enzyme. Yet, 
the replacement of zinc ions by copper ions in the active site is able to confer the 
tyrosinase and DHICA oxidase activities to TYRP1. Whether this also occurs in 
vivo is unclear at this stage. On the other hand, in view of the existence of 
pathological mutations in the TYRP1 gene, one would expect that TYRP1 has a 
unique enzymatic function in melanogenesis. 
 
Figure 10. TYRP1 and TYR activity assays. (A-C) Spectroscopic activity assays of 
TYR, TYRP1 and TYRP1 variants. Human TYR (residues 19-456); TYRP1, human 
TYRP1 (residues 25-471); TYRP1-3M, TYRP1 triple mutant (Y362F-R374S-T391V); 
Apo TYR, Apo TYRP1 and Apo TYRP1-3M are the corresponding proteins depleted of 
Zn/Cu in the active site. TYR-Zn corresponds to Apo TYR recharged with Zn ions. 
TYRP1-Cu and TYRP1-3M-Cu are the corresponding apo proteins recharged with Cu 
ions. (D) On-plate hydroxylase activity assay. Each well  (numbered) contains 100 µl 
pre-reaction mix. 2*, 4*and 6* contain a mixture of tyrosinase inhibitors as negative 
control: 5mM tropolone and 1mM PTU. Well 1 (w1) contains only pre-reaction mix as 
a blank control. In wells 2 to 6, different enzymes were added: w2 and w2*, 5 µg TYR; 
w3, 50 µg TYRP1; w4 and w4*, 50 µg TYRP1-Cu; w5, 50 µg TYRP1-3M; w6 and w6*, 
50 µg TYRP1-3M-Cu. The pink pigment product is the tyrosinase activity product 
dopaquinone in complex with MBTH (quinone-MBTH adduct), which appears after ~1 
min for TYR, ~20 min for TYRP1-3M-Cu, and ~40 min for TYRP1-Cu, and 
accumulates over time. Almost no pigment production in the first 10 min in w4 and w6 
is consistent with the spectroscopic measurement in (A), where nearly no absorbance 
increase is detected in the first 10 min, presumably due to the lag phase problem 
occurring in tyrosinases. w2*, w4*and w6* generate no pigment due to the presence of 
tyrosinase inhibitors, indicating that the reactions in these wells are specific for 




















































































































































































activity, in the first step). W3 and w5 show no pigment, indicating that TYRP1 and 
TYRP1-3M have no hydroxylase activity, which  is consistent with the result from (A). 
Thus, the w3 and w5 wells can be considered as negative controls for w4 and w6, 
respectively. Comparing w4 and w6 at the same time point, w6 is always darker than w4, 
indicating that TYRP1-3M-Cu presents a higher hydroxylase activity than TYRP1-Cu, 
since equal amounts of proteins were used in the two reactions. 
2.5	Structural	basis	of	TYRP1-substrate/inhibitor	interactions	
In view of the similarity of TYRP1 to tyrosinases, we investigated the 
interaction of TYRP1 with typical tyrosinase substrates and inhibitors. A 2.8 Å 
resolution structure (Table 1) shows that L-tyrosine binds in the active site via a 
salt bridge interaction of its carboxylate with the Arg374 side chain (Figure 
11A). In chains A and C its amino group is close enough for hydrogen bonding 
with the Oγ atom of Thr391, but not in chains B and D, suggesting that this 
interaction is not very specific. The aromatic side chain of L-tyrosine has an 
offset stacking interaction with His381 (at 3.8Å), and its hydroxyl group is 
hydrogen bonded to the hydroxyl group of Ser394 and the water molecule 
bridging the two zinc ions in the active site (Figure 11A). Notably, tyrosine does 
not interact directly with the zinc ions, in contrast to the situation in BmTYR, 
where tyrosol (a tyrosine analog) coordinates Cu-A (Goldfeder et al., 2014). 
Compared to BmTYR, in TYRP1 tyrosine is bound with additional hydrogen 
bonds with Ser394, Thr391, and a water molecule stabilized by Tyr362.  
L-mimosine ((S)-α-amino-β-[1-(3-hydroxy-4-oxopyridine)]-propanoic acid) is 
an analog of L-DOPA and an inhibitor of mushroom tyrosinase (Cabanes et al., 
1987). As revealed by a 2.6 Å resolution crystal structure (Table 1), L-mimosine 
binds in a similar way as L-tyrosine (Figure 11B). Its Cζ−keto group is 
hydrogen bonded to the hydroxyl group of Ser394 and the bridging water 
molecule, while its ε-hydroxyl group interacts with the bridging water molecule. 
Its carboxylate is bound by the Nε atom of Arg374 and, via a water molecule, to 
Tyr362. Like with L-tyrosine, L-mimosine does not directly interact with the 
zinc ions in the active site. Its density is better defined than the density for L-
tyrosine, suggesting that the interactions of the ε-hydroxyl group increase the 
binding affinity of mimosine.  
To investigate how amino acid differences between the active sites of TYRP1 
and TYR affect the substrate-binding mode, we solved a 2.4 Å resolution 
structure of the triple mutant TYRP1-3M (see above, Table 1 and Figure 12A) 
with bound L-mimosine (Figure 12B). Despite removal of hydrogen-bonding 
interactions by the Tyr362Phe, Thr391Val, and Arg374Ser mutations, mimosine 
binds in a similar conformation as in native TYRP1. Apparently, the stacking 
interaction of the mimosine aromatic ring with His381 and the water-mediated 
hydrogen bonds of its aromatic keto- and hydroxyl groups are sufficient for 
binding. Two of the three mutated residues, Tyr362 and Arg374, are located at 
the entrance to the active site. In plant tyrosinases (Bijelic et al., 2015) residues 
in this region have been proposed to pre-orient the substrate through electrostatic 
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and hydrophobic interactions. However, in TYRP1 such interactions do not 
appear to be essential since the Tyr362Phe and Arg374Ser mutations did not 
change the binding mode of mimosine (Figure 12), and both TYRP1-Cu and 
TYRP1-3M-Cu have DHICA oxidase activity (Figure 10D). Thus, for TYRP1 a 
“substrate-guiding” function for these residues seems unlikely. 
Figure 11. Binding modes of tyrosinase substrates and inhibitors to TYRP1.  (A) L-
tyrosine, and (B) mimosine bind in the active site. Their carboxylate groups form 
hydrogen bonds with R374. (C) tropolone, and (D) kojic acid bind in the same position 
in the active site as tyrosine and mimosine. Each compound is shown with its 2Fo-Fc 
electron density map (grey wire) contoured at 0.9 σ. Zinc ions (A and B) are shown as 
orange spheres and water molecules as red spheres. Contacts of the compounds with 
TYRP1 residues and the Zn coordination are shown as grey dashed lines. 
The crystal structure of TYRP1 with bound tropolone (2-hydroxy-2,4,6-
cycloheptatriene-1-one), an established tyrosinase inhibitor, shows a direct 
coordination of its O1 and O2 oxygen atoms to the Zn-A ion (at ~1.85 and 2.5 Å, 
respectively, Figure 11C), in contrast to the water-mediated interactions made 
by tyrosine and mimosine (Figure 11A-B). The tropolone molecule stacks on 
the side chain of the Zn-B interacting His381. Interestingly, Zn-A has shifted by 
1.5 Å towards tropolone compared to native TYRP1, indicating that the metal 
ion site is somewhat flexible. Furthermore, the zinc ion in the interface between 
the A and B monomers in the TYRP1 structure is not present anymore in the 
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tropolone-bound TYRP1 structure. The excess of tropolone used during crystal 
soaking may have removed this zinc ion, since tropolone is a strong metal 
chelator.  
Kojic acid (5-hydroxy-2-(hydroxymethyl)-γ-pyrone) is an intensively studied 
tyrosinase inhibitor that is applied as a skin whitening agent in the cosmetic 
industry (Cabanes et al., 1994), and as a food additive to prevent enzymatic 
browning of agricultural products (Chang, 2009). It binds in the active site, with 
its aromatic ring stacking on the side chain of His381, and its ring hydroxyl 
group hydrogen bonding to the Ser394 side chain (Figure 11D). Its ring 
hydroxyl and keto groups are at ~3 Å from the zinc ions, which is too far for a 
good coordination, although they are located much closer than the 7 Å distance 
observed in the kojic acid-bound BmTYR crystal structure (Sendovski et al., 
2011). Furthermore, crystal structures of TYRP1-3M with tropolone and kojic 
acid (Table 1) show almost identical binding modes as wild-type TYRP1. Taken 
together, our results provide further support for the notion that the 
presence/absence of “substrate-guiding residues” at the active site entrance does 
not affect the binding mode of inhibitors. 
 
Figure 12. Substrate-binding mode of TYR-mimicked TYRP1 active site. (A) 
Active site of the TYRP1-3M mutant (Y362F-R374S-T391V), which mimics the TYR 
active site, and (B) active site of TYRP1-3M with bound mimosine. TYRP1-3M has an 
identical metal ion coordination to that of native TYRP1. Furthermore, mimosine binds 
very similarly to native TYRP1, indicating that the stacking interaction of the mimosine 
aromatic ring with His381 residue and the water-mediated hydrogen bonds of its 
aromatic keto- and hydroxyl groups are sufficient for binding. Mutated residues are 
highlighted in green. Mimosine is show as green sticks within a green molecular surface. 
2.5	Structural	rationalization	of	OCA3	disease	related	mutations	
According to the Human Gene Mutation Database (Stenson et al., 2009), 15 
OCA3-related mutations have been found in the TYRP1 gene, including seven 
point mutations, two nonsense mutations, five deletions and one indel. Of the 7 
point mutations (Cys30Arg (Yamada et al., 2011), His215Tyr (Zhang et al., 
2011), Thr253Met (Hutton and Spritz, 2008b), Cys290Tyr (Gargiulo et al., 
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2011), Arg356Gln (Rooryck et al., 2006), Met452Val (Hutton and Spritz, 2008b) 
and Pro513Arg (Chiang et al., 2009); Figure 13), residues Cys30 and Cys290 
are involved in disulfide bonds that are critical for stabilizing the α1 and α5 
helices (comprising residues 33-38 and 293-299, respectively, Figure 13); 
His215 is a ZnA ligand in the active site; R356 forms an extensive hydrogen 
bonding network with residues located on loop α6-α7 (Phe342, Asp343 and 
Tyr346, respectively) and helix α7 (Glu360) in the vicinity of active site, and has 
also hydrophobic interactions with Leu221 and Phe342. R356 thus seems critical 
for stabilizing helices α6 and α7 in the core of the protein. Moreover, Arg356 is 
also present in TYR and TYRP2, which supports a critical role in maintaining 
the stability of melanogenic proteins in general. Pro513Arg is the only mutation 
that is not mapped in the current structure; it belongs to the conserved di-leucine 
motif EKQPLL in the cytosolic tail domain, which is critical for targeting 
melanogenic proteins to the melanosomal membrane (Calvo et al., 1999; Höning 
et al., 1998; Setaluri, 2000). The replacement of a proline by an arginine residue 
thus may interfere with translocation of TYRP1 to the melanosomal membrane. 
Finally, Thr253Met and Met452Val are two novel missense mutations found in 
Caucasian OCA3 patients, that are yet to be confirmed as pathological mutations 
(Hutton and Spritz, 2008b). Thr253 is located on a loop at the protein surface 
and far away from the active site, making it unlikely that its substitution will 
directly affect the activity of the protein. However, the introduction of a large 
apolar methionine at this position may lead to local unfolding and/or aggregation, 
and affect the stability of the enzyme. Met452 is located in the interface between 
the Cys-rich and tyrosinase-like subdomains. Its side chain has hydrophobic 
interactions with the apolar parts of the side chains of Thr222, Arg225, Tyr226, 
Met440, and Leu460. Its replacement by the smaller valine side chain would 
retain the interactions with Thr222 and Met440, but the other interactions would 
be reduced, which may have a (probably minor) effect on the stability of the 
enzyme. Interestingly, the Arg93Cys substitution in TYRP1 has been shown to 
cause blond hair in normally black haired Melanesian individuals(Kenny et al., 
2012). Arg93 is located in the vicinity of a cluster of four disulfide bonds in the 
Cys-rich subdomain (Figure 9), suggesting that a cysteine introduced at position 
93 could interfere with correct disulfide bond formation or even prevent correct 
folding of the protein.  
Overall, the crystal structure of TYRP1 provides a structural rationalization of 
most of the associated OCA3 disease related mutations. Furthermore, our 
structural analysis may provide further insights into the mechanisms of disease 





The TYRP1 amino acid sequence contains the sequence motifs that, in 
tyrosinases, catechol oxidases, and hemocyanins, define a type-3 binuclear 
copper-binding site (Figure 3), implying that TYRP1 may also bind copper ions. 
Yet, previous in vivo studies have been unable to establish copper ion binding to 
TYRP1 in melanocytes (Furumura et al., 1998). In agreement with those 
observations, we did neither detect the presence of copper ions in TYRP1 
crystals. Instead, X-ray fluorescence measurements showed the presence of zinc 
ions (Figure 8), which we further confirmed by single wavelength anomalous 
dispersion diffraction data, demonstrating that the zinc ions in TYRP1 are 
located at the positions occupied by the copper ions in tyrosinases. The in vivo 
studies58 also analyzed the presence of zinc ions in TYRP1, but no evidence was 
obtained for this, probably because of the low specific activity and short half-life 
of the 65Zn isotope used for those studies. Remarkably, although we carried out 
the production of TYRP1 and TYR samples under identical cell culture 
conditions and in the absence of external sources of zinc or copper ions in the 
media, the two proteins clearly contain different ions (Figure 8), unambiguously 
proving that TYR is a copper-binding enzyme while TYRP1 is a zinc-binding 
enzyme. 
3.2	The	reaction	catalysed	by	TYRP1	
The catalytic activity of TYRP1 has been under a long debate. Kobayashi et al. 
(Kobayashi et al., 1994b) provided evidence that murine TYRP1 catalyzes the 
oxidation of DHICA to a carboxylated indole-quinone, but human TYRP1 did 
not show this activity(Boissy et al., 1998). On the other hand, Zhao et al. (Zhao 
et al., 1994) concluded that human TYRP1 has tyrosine hydroxylase, but not 
DOPA oxidase activity. However, our finding that TYRP1 contains zinc instead 
of copper in its active site makes an oxidation reaction unlikely, because zinc is 
not a redox-active ion and cannot activate oxygen. Since none of the previous 
studies were done with purified recombinant TYRP1, we compared the activities 
of purified recombinant intra-melanosomal TYR and TYRP1 (Figures 6 and 10). 
TYR shows the expected tyrosine hydroxylase and L-DOPA oxidase activities 
(Figure 10A-B), but, to our surprise, it also presents DHICA oxidase activity 
(Figure 10C). In contrast, TYRP1 has neither hydroxylase nor oxidase activities 
(Figure 10A-C), consistent with our finding that TYRP1 contains redox-inactive 
zinc ions in the active site. Interestingly, substitution of zinc by redox-active 





Figure 13. The OCA3 disease and blond hair derived mutations mapped in the 
structure of TYRP1. The Cys-rich subdomain is shown in light green and the 
tyrosinase-like subdomain in blue. The OCA3-related single-residue mutations are 
pictured as red sticks surrounded by surfaces. Native residues are shown as green sticks. 
The blond hair mutation is R93C. The disulfide bond cluster is indicated, and the 
disulfide bonds are shown as orange sticks. The Zn-B ion is shown as an orange sphere, 
while the Zn-A ion occupies the same position as the hydroxyl group of the newly 
introduced tyrosine residue (H215Y). The N and C labels correspond to the N- and C-
terminus, respectively. 
Our TYRP1 substrate- and inhibitor-bound crystal structures show that TYRP1 
binds tyrosine and L-DOPA analogs (Figure 11), but does not have extensive 
interactions with the α-amino group of these compounds. Similarly, although 
Arg374 makes a salt bridge with the carboxylate, its mutation to a serine does 
not change the binding mode of L-mimosine (Figure 11B). Taken together, we 
conclude that the interactions of TYRP1 with the α-amino and carboxylate 
groups are of minor importance. Most important, however, is the presence of 
zinc, which prevents oxidation of the substrate, and which leads us to suggest 
that TYRP1 might catalyze a protonation/deprotonation reaction via the bridging 
water molecule and Ser394. Such a reaction could result in the production of a 
phenolate intermediate, which can be further oxidized by tyrosinase. In general, 
zinc containing enzymes are usually used for hydrolytic, condensation, or other 
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atom and group transfer reactions due to its flexible coordination geometry, fast 
ligand exchange, Lewis acidity, intermediate polarizability, availability, strong 
binding to suitable sites, and its lack of redox activity (Vallee and Auld, 1993). 
In the catalytic mechanism of tyrosinases, a phenolate is usually suggested as an 
intermediate before hydroxylation reaction (Bijelic et al., 2015; Goldfeder et al., 
2014). If this is also the case for TYR, then, according to our hypothesis, TYRP1 
could act as a “helper” for TYR, producing a phenolate intermediate from 
DHICA. TYR could then carry out the oxidation reaction using this intermediate 
to produce indole-5,6-quinone-carboxylic acid and probably leading to more 
efficient eumelanin synthesis (Figure 1). Notably, OCA3 patients with deficient 
TYRP1 usually show deficiency of black eumelanin (Sarangarajan and Boissy, 
2001). Furthermore, our proposed activity seems compatible with some data 
showing that TYRP1 stabilizes TYR activity (Hearing et al., 1992; Kobayashi et 
al., 1998), and that TYRP1 and TYR form heterodimers (Jiménez-Cervantes et 
al., 1998; Kobayashi and Hearing, 2007) and constitute a melanogenic complex 
in vivo together with TYRP2 (Orlow et al., 1994), presumably facilitating 
substrate exchange (Jiménez-Cervantes et al., 1998).  
4.	Conclusions	
In summary, we present here the first crystal structure of a mammalian 
tyrosinase family member. Intra-melanosomal human tyrosinase-related protein 
1 (TYRP1) shows a typical tyrosinase fold and a Cys-rich subdomain that is 
unique to vertebrate melanogenic proteins. The presence of two zinc ions in the 
active site makes it unlikely that human TYRP1 is a redox enzyme, in contrast to 
what has been assumed for the last three decades. Our activity assays provide 
further evidence that TYRP1 has neither hydroxylase nor oxidase activities, in 
contrast to human TYR. Very interestingly, the substitution of zinc by redox-
active copper ions is able to confer to TYRP1 tyrosinase activity. These findings 
are in accordance with previous studies suggesting that the human tyrosinase 
family shares structural features although their metal binding properties might be 
distinct. Furthermore, our crystal structures of TYRP1 with bound tyrosinase 
substrates and inhibitors show a similar ligand binding mode to tyrosinases and a 
mutated TYRP1 that mimics TYR second-shell residues at the active site 
entrance, providing further support for the presumption that the “substrate-
guiding residues” in the active site entrance do not affect the TYRP1 binding 
mode, which would be mainly driven by the metal ligand. Finally, the crystal 
structure of TYRP1 provides a structural rationalization of oculocutaneous 
albinism type 3 (OCA3) related mutations, which can provide insights into the 
disease mechanisms and guide structure-based design of compounds for 




The intra-melanosomal domain (residues 25-471) of human TYRP1, a truncated 
version of the full-length protein without the single-transmembrane domain and 
the cytosolic tail was chosen for our crystallographic study. The TYRP1 native 
N-terminal signal peptide (residues 1-24) was included in the construct to 
facilitate the secretion of the protein for post-translational modifications (such as 
glycosylation) in insect cell expression systems. Thus, a codon-optimized gene 
encoding TYRP1 signal peptide and the intra-melanosomal domain followed by 
a Tobacco Etch Virus (TEV) cleavage site (ENLYFQG) and a hexa-histidine tag 
was commercially synthesized and inserted into pACEBac1 vector (Geneva 
Biotech) between SacI and XbaI restriction cloning sites. The resulting plasmid 
was confirmed by DNA sequencing (Macrogen Inc.) and subsequently 
transformed into DH10BacY bacterial competent cells for the production of 
recombinant bacmids. The cells were incubated overnight at 310 K and 
subsequently plated on an agar plate containing kanamycin (50 µL/mL), 
gentamycin (10 µL/mL), tetracycline (10 µL/mL), isopropyl-β-D-1-
thiogalactopyranoside (IPTG, 1 mM) and Bluo-Gal (100 µL/mL, Thermo Fisher 
Scientific Inc.) for blue-white screening to identify colonies containing the 
recombinant bacmid. A single white colony containing recombinant bacmids 
was picked and inoculated into 2 mL medium for bacmid extraction and 
purification. Purified DNA product was then mixed with DNA transfection 
reagent (X-tremeGENE HP, Roche) and used to transfect 3 mL of a culture 
containing one million Sf21 insect cells (Thermo Fisher Scientific), according to 
manufacturer’s protocol. Recombinant baculoviruses in the supernatant were 
harvested after 72 h incubation and used to subsequently infect 25 mL of Sf21 
cell culture (at a density of ~0.7 million cells per mL). High multiplicity of 
infection virus stocks were harvested after around 108 h and stored at 277 K for 
long-term use. 
5.2	Protein	expression	and	purification	
For large-scale expression, 4 mL recombinant baculovirus stock solution was 
used to infect 4 liters Sf21 cells (at a density of ~1.0 million cells per mL). After 
culturing for ~108 h, the medium was clarified by centrifugation at 6000 g and 
subsequently concentrated to ~100 mL using a 10 kDa cut-off QuixStand 
Benchtop System (GE Healthcare). The concentrated medium was then 
incubated with 5 mL of Ni-NTA agarose resin (QIAGEN) for 20 min, which was 
then applied to a 20 mL gravity flow chromatography column (Econo-Pac 
column, Bio-Rad). The flow-through was discarded and the bound protein was 
washed with 2 column volumes (CV) of wash buffer (25 mM Tris-HCl, pH 7.8, 
150 mM NaCl, 50 mM imidazole) and eluted with 1 CV of elution buffer (25 
mM Tris-HCl, pH 7.8, 150 mM NaCl, 500 mM imidazole). TEV protease was 
added to the eluted protein solution and dialyzed overnight at 273 K against 
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dialysis buffer (25 mM Tris-HCl, pH 7.8, and 150 mM NaCl) to cleave the C-
terminal 6xHis-tag. TEV protease and uncleaved protein were removed by 
nickel affinity chromatography. Cleaved human TYRP1 protein in the flow-
through was collected and buffer-exchanged to ion-exchange buffer (25 mM 
Tris-HCl, pH 8.8, 50 mM NaCl). The resulting protein solution was then applied 
to a MonoQ column (GE Healthcare) pre-equilibrated with the ion-exchange 
buffer. The flow-through fractions with pure TYRP1 protein were pooled, 
concentrated and applied to a final gel filtration chromatography column 
(Superdex-200; GE Healthcare) pre-equilibrated with crystallization buffer (10 
mM Tris-HCl, pH 7.8, 100 mM NaCl). The elution fractions containing the pure 
protein were finally pooled and concentrated over a 30 kDa cut-off Amicon 
membrane (Millipore) to ~25 mg/mL for crystallization screening. 
Recombinant expression, purification and crystallization of human TYR intra-
melanosomal domain (residues 19-456) have been reported elsewhere (Lai et al., 
2016b). 
5.3	Crystallization	
Initial screening for crystallization conditions was performed by the HTX 
crystallization facility (EMBL-Grenoble, France). The crystallization screens 
were set up by sitting-drop vapor-diffusion using three protein and reservoir 
ratios (3:1, 1:1 and 1:3). All crystallization trials were done at 293 K. Crystals 
appeared in a condition containing 0.1 M Tris (pH 7.0), 0.2 M NaCl and 30% 
(w/v) PEG 3000, with a protein to reservoir ratio of 3:1. This condition was 
manually optimized by mixing 1.5 µl protein solution with 0.5 µl reservoir 
solution, and varying the pH and PEG 3000 concentration. Rod-like crystals 
appeared in 2 days and grew to full size in 7 days. Tyrosine was introduced in 
the crystals by soaking them with tyrosine powder, directly added and incubated 
overnight before harvesting for diffraction tests. Soaking of tropolone, kojic acid 
or mimosine was carried out by crystal soaking in a cryo-drop (reservoir solution 
supplemented with 20% (v/v) glycerol) containing the corresponding powder for 
5 to 10 min before harvesting for diffraction tests. TYRP1-3M native and ligand-
bound crystals were crystallized and prepared following a similar protocol as 
that of native TYRP1.  
5.4	Data	collection	and	processing	
Crystals were mounted in cryo loops and subsequently flash-frozen in liquid 
nitrogen. X-ray diffraction data for native and ligand-bound TYRP1 crystals 
were collected at 100 K at the ESRF beamlines ID23-1 or ID29 (Grenoble, 
France) (Table 1). Ligand-bound TYRP1-3M crystals were collected at the 
ESRF MASSIF-1 automated beamline (Bowler et al., 2015). Native crystals 
diffracted up to 2.3  Å, ligand-bound TYRP1/TYRP1-3M crystals diffracted 
between 2.5  and 2.8  Å. The data sets were processed and integrated using the 
program XDS(Kabsch, 2010) in combination with the program SCALA(Evans, 
2006) from the CCP4 package (Winn et al., 2011). The crystals belong to space 
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group P212121. For phasing native TYRP1, a modified model of tyrosinase from 
Bacillus megaterium (PDB: 3NM8) (Sendovski et al., 2011) was generated with 
CHAINSAW (Stein, 2008) by pruning non-conserved residues. Molecular 
replacement was carried out with PHASER (McCoy et al., 2007) using this 
model. The resulting single solution gave four molecules in the asymmetric unite, 
with each molecule displaying clear electron density for residues 126 to 467. 
Clear difference density was present for the missing N-terminal residues 
(residues 25-125). Further manual model rebuilding and refinement were 
iteratively performed with COOT and PHENIX (Adams et al., 2010), 
respectively. The missing residues were subsequently added manually in COOT 
(Emsley et al., 2010). Ligand bound TYRP1/TYRP1-3M structures were solved 
by molecular replacement using native TYRP1 as a search model. Statistics of 
data collection and refinement are summarized in Table 1. 
To confirm the presence of zinc ions in the native TYRP1 crystal, a single-
wavelength anomalous dispersion (SAD) experiment was carried out on a single 
crystal. The SAD data was measured at beamline ID23-1 (ESRF, Grenoble) at 
the zinc K-edge (9.67 keV) (Table 1). The data set was processed and integrated 
using the program XDS (Kabsch, 2010) from the CCP4 package (Winn et al., 
2011). The native and the anomalous data sets were then merged with the 
program CAD to generate an anomalous difference Fourier map using the zinc 
anomalous signal with the program FFT from the CCP4 package (Winn et al., 
2011). 
5.5	X-ray	fluorescence	data	collection	and	processing	
X-ray fluorescence data were collected at ESRF beamline ID23-1 with an 
incident beam energy of 12.7 keV, an exposure time of 1 s and a transmitted 
beam intensity of 2.2% (Leonard et al., 2009). Analysis of the X-ray 
fluorescence spectrum was handled by PyMCA (Python multichannel analyzer) 


























Beamline ID23-1 ID23-1 ID23-1 ID29 ID29 MASSIF1 MASSIF1 MASSIF1 ID23-1
Wavelength	(Å) 0.976 0.976 0.976 0.976 0.976 0.976 0.976 0.976 1.282
Space	group P212121 P212121 P212121 P212121 P212121 P212121 P212121 P212121 P212121
Cell	dimensions	
(Å)
a 90.42 89.52 89.69 89.79	 90.25,	 89.35	 89.73 89.64	 89.63
b 141.76 140.32 140.20 141.08 141.54 139.73 140.60 140.43 142.29
c 191.74 191.68 191.06 192.26 192.13 190.95 191.25 191.56 192.17



















Rmerge (%) 16.7	(109.4) 12.6	(89.3) 23.1	(85.4) 31.1	(183.7) 14.4	(99.2) 12.4	(89.6) 9.6	(85.1) 18.7	(136.3) 11.5	(38.6)
I	/	σI 6.6	(1.2) 7.6	(1.4) 6.0	(1.7) 5.7	(1.7) 9.0	(1.6) 12.6	(2.1) 11.9	(1.6) 9.9	(1.4) 26.6	(8.3)
Completeness	(%) 99.7	(99.8) 99.4	(99.7) 99.8	(99.8) 99.2	(99.8) 99.8	(100) 100	(100) 99.7	(99.2) 100	(100)
100	(99.9)
Redundancy 4.8	(4.9) 3.3	(3.4) 4.8	(4.9) 4.2	(4.4) 4.6	(4.8) 4.8	(7.0) 4.3	(4.0) 6.7	(6.6) 16.4	(15.7)
Anomalous	
correlation	(%)
-- -- -- -- -- -- -- -- 26
Refinement
Resolution	(Å) 48.98-2.35 48.76-2.8 48.69-2.5 48.92-2.6 49.00-2.65 48.60-2.40 48.75-2.35 48.77-2.85
No.	reflections 102,816 59,734 83,673 74,895 71,595 94,135 10,0975 57,320
Rwork /	Rfree (%) 21.40/25.49 20.46/26.20 20.43/25.12 21.94/27.45 19.67/24.94 20.01/24.86 18.28/22.54 20.79/27.54
No.	of	atoms
Protein 14240 14240 14240 14240 14240 14216 14216 14216
Water 181 65 179 272 43 39 577 4
Carbohydrate 696 750 746 617 689 486 678 466
Zn 9 9 8 9 9 9 8 9
Ligand 52 36 56 40 56 36 40
B	factors
Protein 38.946 53.577 24.204 45.102 38.689 38.544 42.728 56.813
Water 31.365 41.504 20.888 41.274 30.626 30.737 44.080 50.723
Carbohydrate 59.375 77.788 45.187 61.171 58.645 53.966 60.925 66.491
Zn 43.727 50.281 26.764 40.713 44.273 29.278 38.359 54.838
Ligand 62.975 20.319 41.800 44.497 34.788 52.855 59.682
r.	m.	s.	d.	
deviations
Bond	lengths	(Å) 0.011 0.014 0.011 0.012 0.012 0.009 0.011 0.011
Bond	anglee	(°) 1.110 1.340 1.140 1.360 1.140 1.130 1.220 1.440
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5.6	Activity	measurements	
Tyrosine hydroxylase and L-DOPA oxidase activities were measured at 298 K 
using L-tyrosine and L-DOPA as substrates, respectively (Espín et al., 1997; 
Winder and Harris, 1991). The 90 µL pre-reaction mix in a 10 mm-path cuvette 
containing 5 mM 3-methyl-2-benzothiazolinone hydrazone hydrochloride 
hydrate (MBTH), 125 mM potassium phosphate buffer, pH 6.8, 2.5% 
dimethylformamide (DMF) and saturated L-tyrosine/L-DOPA was applied to a 
UV-visible spectrophotometer (UV-2401PC mode, Shimadzu Corporation). The 
reaction was started by addition of 10 µL protein solution to the pre-reaction mix, 
and was monitored by measuring the absorbance increment at 507 nm 
wavelength (ε507=38000 M-1 cm-1) in 5 or 10 min. DHICA oxidase activity was 
determined using DHICA (5,6-dihydroxyindole-2-carboxylic acid) as substrate 
in the pre-reaction mix (Kobayashi et al., 1994b). The reaction was monitored by 
measuring the absorbance increment at 470 nm wavelength (ε470=15000 M-1 cm-
1) in 5 or 10 min. The metal depleted protein samples (apo TYRP1, apo TYRP1-
3M and apo TYR) were prepared by incubating the corresponding native protein 
sample with 100 mM KCN in Tris buffer, pH 7.5 at 4 °C overnight. The metal-
substituted protein samples (TYR-Zn, TYRP1-Cu and TYRP1-3M-Cu) were 
prepared by incubating the corresponding apo protein sample with 0.5 mM 
ZnCl2 or CuCl2 in 50 mM Tris buffer, pH 7.5 at room temperature for 3 hours. 
All protein samples were buffer-exchanged to zinc- and copper-free buffer (50 
mM Tris buffer, pH 7.5, 150 mM NaCl) before assays. All measurements were 
performed in duplicates or triplicates. The on-plate hydroxylase activity was 
measured at 298 K using L-tyrosine as substrate in a Nunc™ Edge 96-Well plate 
(Thermo Fisher Scientific). Each well contained 100 µl pre-reaction mix, 
containing 4 mM MBTH, 100 mM potassium phosphate buffer, pH 6.8, 2% 
DMF and 1 mM tyrosine. The colorimetric reaction was started with the addition 
of 10 µL of protein solution to the pre-reaction mix, and was followed by 
monitoring the development of the pink-coloured quinone-MBTH adduct. 
Images were taken using a Photo HP Scanjet G3110 scanner (Hewlett-Packard) 
after 0, 1 min, 10 min, 20 min, 40 min, 80 min and 160 min, respectively. 
5.7	Site-directed	mutagenesis	
TYRP1-3M and all TYR mutant constructs were generated by PCR using 
Phusion DNA polymerase (New England BioLabs). The primers were generated 
by PrimerX (http://www.bioinformatics.org/primerx/) (Table 2), and 
synthesized by Eurofins Genomics. The TYRP1-3M construct was generated 
stepwise in the order of Y362F, R374S and T391V. All mutant constructs were 
confirmed by DNA sequencing (Macrogen Inc.).  
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Table 2. Primers used for site-directed mutagenesis. a underlined letter(s) indicate 
mutated nucleotide(s); b F, forward primer; R, reverse primer. 




GCAATACGGTGGAGGGATTCTCCGACCCGACAGGTAAG  F 
CTTACCTGTCGGGTCGGAGAATCCCTCCACCGTATTGC  R 
R374S 
GATCCTGCGGTAAGCAGCCTGCATAACC F 
GGTTATGCAGGCTGCTTACCGCAGGATC R 
T391V 
CGGTACGGGAGGTCAAGTACACCTGAGCCCTAACG F 
CGTTAGGGCTCAGGTGTACTTGACCTCCCGTACCG R 
 
 
  
